| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |